| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 92.28B | 99.85B | 87.77B | 83.12B | 86.08B | 77.32B |
| Gross Profit | 21.73B | 24.68B | 20.66B | 18.46B | 15.76B | 13.10B |
| EBITDA | 17.72B | 20.89B | 16.78B | 14.61B | 12.50B | 10.12B |
| Net Income | 10.78B | 13.78B | 10.18B | 9.25B | 8.20B | 5.32B |
Balance Sheet | ||||||
| Total Assets | 130.51B | 141.29B | 125.23B | 120.36B | 105.03B | 103.61B |
| Cash, Cash Equivalents and Short-Term Investments | 44.62B | 47.93B | 44.16B | 41.66B | 38.72B | 36.95B |
| Total Debt | 169.00M | 847.00M | 921.00M | 675.00M | 552.00M | 617.00M |
| Total Liabilities | 37.36B | 37.59B | 34.69B | 35.62B | 33.52B | 35.03B |
| Stockholders Equity | 91.16B | 101.60B | 88.58B | 82.98B | 69.88B | 67.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.98B | 8.53B | 5.34B | 7.41B | 7.51B |
| Operating Cash Flow | 0.00 | 13.33B | 13.37B | 8.69B | 9.76B | 9.30B |
| Investing Cash Flow | 0.00 | -4.85B | -5.35B | -3.83B | -7.01B | -2.16B |
| Financing Cash Flow | 0.00 | -4.74B | -5.62B | -2.24B | -1.24B | -6.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥42.62B | 8.17 | ― | 3.74% | 4.73% | 17.57% | |
71 Outperform | ¥32.64B | 8.57 | ― | 3.59% | 6.27% | 28.43% | |
70 Outperform | ¥120.37B | 8.88 | ― | 1.92% | 13.77% | 39.53% | |
68 Neutral | ¥123.13B | 10.61 | 12.89% | 3.40% | 3.44% | -3.09% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥57.99B | 14.86 | ― | 1.49% | 8.57% | 11.82% | |
55 Neutral | ¥98.46B | 43.49 | ― | 3.53% | -3.19% | -4.14% |